Követés
Kevin R. King MD PhD
Kevin R. King MD PhD
UC San Diego Depts of Medicine and Bioengineering, Division of Cardiovascular Medicine
E-mail megerősítve itt: ucsd.edu
Cím
Hivatkozott rá
Hivatkozott rá
Év
Antibody structure, instability, and formulation
W Wang, S Singh, DL Zeng, K King, S Nema
Journal of pharmaceutical sciences 96 (1), 1-26, 2007
10462007
Macrophages facilitate electrical conduction in the heart
M Hulsmans, S Clauss, L Xiao, AD Aguirre, KR King, A Hanley, ...
Cell 169 (3), 510-522. e20, 2017
5862017
Multilayer device for tissue engineering
JT Borenstein, KR King, H Terai, JP Vacanti
US Patent 7,371,400, 2008
5742008
Microfabrication technology for vascularized tissue engineering
JT Borenstein, H Terai, KR King, EJ Weinberg, MR Kaazempur-Mofrad, ...
Biomedical microdevices 4 (3), 167-175, 2002
4572002
A high-throughput microfluidic real-time gene expression living cell array
KR King, S Wang, D Irimia, A Jayaraman, M Toner, ML Yarmush
Lab on a Chip 7 (1), 77-85, 2007
2762007
IRF3 and type I interferons fuel a fatal response to myocardial infarction
KR King, AD Aguirre, YX Ye, Y Sun, JD Roh, RP Ng, RH Kohler, ...
Nature medicine 23 (12), 1481-1487, 2017
2552017
Immunogenicity of protein aggregates—concerns and realities
W Wang, SK Singh, N Li, MR Toler, KR King, S Nema
International journal of pharmaceutics 431 (1-2), 1-11, 2012
2362012
Biodegradable microfluidics
KR King, CCJ Wang, MR Kaazempur‐Mofrad, JP Vacanti, JT Borenstein
Advanced Materials 16 (22), 2007-2012, 2004
2342004
Dynamic gene expression profiling using a microfabricated living cell array
DM Thompson, KR King, KJ Wieder, M Toner, ML Yarmush, A Jayaraman
Analytical chemistry 76 (14), 4098-4103, 2004
1892004
Myocardial infarction activates CCR2+ hematopoietic stem and progenitor cells
P Dutta, HB Sager, KR Stengel, K Naxerova, G Courties, B Saez, ...
Cell stem cell 16 (5), 477-487, 2015
1732015
Living-cell microarrays
ML Yarmush, KR King
Annual review of biomedical engineering 11, 235, 2009
1542009
Gap junction inhibition prevents drug-induced liver toxicity and fulminant hepatic failure
SJ Patel, JM Milwid, KR King, S Bohr, A Iracheta-Vellve, M Li, A Vitalo, ...
Nature biotechnology 30 (2), 179-183, 2012
1322012
Microfluidic flow-encoded switching for parallel control of dynamic cellular microenvironments
KR King, S Wang, A Jayaraman, ML Yarmush, M Toner
Lab on a Chip 8 (1), 107-116, 2008
1042008
Protective role of cross-reactive CD8 T cells against dengue virus infection
AE Ngono, HW Chen, WW Tang, Y Joo, K King, D Weiskopf, J Sidney, ...
EBioMedicine 13, 284-293, 2016
782016
DNA-triggered innate immune responses are propagated by gap junction communication
SJ Patel, KR King, M Casali, ML Yarmush
Proceedings of the National Academy of Sciences 106 (31), 12867-12872, 2009
672009
Optimization of reporter cells for expression profiling in a microfluidic device
KJ Wieder, KR King, DM Thompson, C Zia, ML Yarmush, A Jayaraman
Biomedical microdevices 7 (3), 213-222, 2005
662005
Tissue-specific macrophage responses to remote injury impact the outcome of subsequent local immune challenge
FF Hoyer, K Naxerova, MJ Schloss, M Hulsmans, AV Nair, P Dutta, ...
Immunity 51 (5), 899-914. e7, 2019
602019
Aggregation and pH–temperature phase behavior for aggregates of an IgG2 antibody
E Sahin, WF Weiss IV, AM Kroetsch, KR King, RK Kessler, TK Das, ...
Journal of pharmaceutical sciences 101 (5), 1678-1687, 2012
542012
Point-of-care technologies for precision cardiovascular care and clinical research: National Heart, Lung, and Blood Institute Working Group
KR King, LP Grazette, DN Paltoo, JT McDevitt, SK Sia, PM Barrett, ...
JACC: Basic to Translational Science 1 (1), 73-86, 2016
482016
Fabrication of vascularized tissue using microfabricated two-dimensional molds
JP Vacanti, YMM Shin, J Ogilvie, A Sevy, T Maemura, O Ishii, ...
US Patent 8,642,336, 2014
452014
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20